345 related articles for article (PubMed ID: 15531516)
1. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation.
Tarkun I; Arslan BC; Cantürk Z; Türemen E; Sahin T; Duman C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5592-6. PubMed ID: 15531516
[TBL] [Abstract][Full Text] [Related]
2. Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome.
Tarkun I; Cetinarslan B; Türemen E; Sahin T; Cantürk Z; Komsuoglu B
Eur J Endocrinol; 2005 Jul; 153(1):115-21. PubMed ID: 15994753
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
5. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
Kravariti M; Naka KK; Kalantaridou SN; Kazakos N; Katsouras CS; Makrigiannakis A; Paraskevaidis EA; Chrousos GP; Tsatsoulis A; Michalis LK
J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
[TBL] [Abstract][Full Text] [Related]
7. Low grade chronic inflammation in women with polycystic ovarian syndrome.
Kelly CC; Lyall H; Petrie JR; Gould GW; Connell JM; Sattar N
J Clin Endocrinol Metab; 2001 Jun; 86(6):2453-5. PubMed ID: 11397838
[TBL] [Abstract][Full Text] [Related]
8. Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome.
Ruan X; Dai Y
Med Princ Pract; 2009; 18(2):118-22. PubMed ID: 19204430
[TBL] [Abstract][Full Text] [Related]
9. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.
Mather KJ; Verma S; Corenblum B; Anderson TJ
J Clin Endocrinol Metab; 2000 May; 85(5):1851-6. PubMed ID: 10843164
[TBL] [Abstract][Full Text] [Related]
10. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
11. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
Hu W; Qiao J; Yang Y; Wang L; Li R
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057
[TBL] [Abstract][Full Text] [Related]
12. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.
El-Mesallamy HO; Abd El-Razek RS; El-Refaie TA
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):178-82. PubMed ID: 23434327
[TBL] [Abstract][Full Text] [Related]
13. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
[TBL] [Abstract][Full Text] [Related]
15. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
[TBL] [Abstract][Full Text] [Related]
16. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
[TBL] [Abstract][Full Text] [Related]
17. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD
J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
[TBL] [Abstract][Full Text] [Related]
19. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?
Wijeyaratne CN; Nirantharakumar K; Balen AH; Barth JH; Sheriff R; Belchetz PE
Clin Endocrinol (Oxf); 2004 May; 60(5):560-7. PubMed ID: 15104558
[TBL] [Abstract][Full Text] [Related]
20. Retinol-binding protein 4, as a negative acute-phase reactant in polycystic ovary syndrome.
Güdücü N; Görmüş U; Telatar B; Dünde I
Minerva Endocrinol; 2014 Dec; 39(4):299-304. PubMed ID: 25371056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
